Advertisement

Topics

Constance Marie Company Profile

14:12 EDT 20th September 2017 | BioPortfolio


News Articles [82 Associated News Articles listed on BioPortfolio]

stimOS: Constance-based Start-Up Company gains HTGF and MBG as investors

German HTGF acts as seed investor at stimOS GmbH located in Constance: Together with MBG, Baden-Württemberg (MBG), the seed stage investor provides 720,000 euros for further development and approval ...

This Woman's Viral Post About Being a "Bad Mom" Is So Relatable

And what Constance Hall learned from a therapist is something every mom should keep in mind.

Author Marie Florence’s Newly Released “Ree’s Chronicles: The Price I Paid For A Cup Of Sugar” A Gripping Story Of Tragic Life Events And Learning To Surrender To God

(PRWEB) September 07, 2017 “Ree’s Chronicles: The Price I Paid for a Cup of Sugar”: a captivating and inspiring story...

We must believe that we are gifted for something, and that this thing, at whatever cost, must be attained.

Marie Curie, physicist and chemist

Flex???s Phase II Trial With FLX-787 In Charcot-Marie-Tooth Endorsed By

  Life Sciences Jobs   ...

Flex Pharma???s Phase II Trial With FLX-787 In Charcot-Marie-Tooth Endorsed By

  Life Sciences Jobs   ...

Acceleron Pharma Announces First Patient Treated In Phase II Clinical Trial Of ACE-083 In Charcot-Marie-Tooth Disease

  Life Sciences Jobs   ...

PHARNEXT Announces That The Recommends Continuing The Ongoing Phase III Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A

  Life Sciences Jobs   ...

PubMed Articles [42 Associated PubMed Articles listed on BioPortfolio]

Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score.

Charcot-Marie-Tooth Disease type 1A (CMT1A) is caused by a duplication of the peripheral myelin protein gene 22 at chromosome 17p11.2-12. There is limited data regarding whether body mass index (BMI) ...

Radium discovery by Marie and Pierre Curies caused previously unknown diseases. Marie Sklodowska Curie (1867-1934) suffered from radiations effects, as did girls in the radium dial watches factories. ...

Natural history of Charcot-Marie-Tooth disease during childhood.

To determine the rate of disease progression in a longitudinal natural history study of children with Charcot-Marie-Tooth disease (CMT).

Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

To analyse and describe the clinical and genetic spectrum of Charcot-Marie-Tooth disease (CMT) caused by mutations in the neurofilament light polypeptide gene (NEFL).

Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).

Charcot-Marie-Tooth disease (CMT) type 1A is the most common form of CMT 1 and one of the autosomal dominant demyelinating hereditary motor and sensory neuropathies (HMSN). Cranial nerves may be frequ...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)

The purpose of this study is to develop and validate a clinical outcome measure to evaluate disability and disease progression of children 3 years of age and younger (infants and toddlers)...

Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease

The object of this research is to test the effectiveness of Coenzyme Q10 (CoQ10) on symptoms of weakness, fatigue, and pain in persons with Charcot-Marie-Tooth disease (CMT).In this study ...

Follow up and Observation of Charcot Marie Tooth Disease in Families

The study is aimed to test the hypothesis that there is anticipation in CMT

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

This is a multicenter, phase 2 study to evaluate the safety, tolerability, pharmacodynamics (PD), efficacy, and pharmacokinetics (PK) of ACE-083 in patients with CMT1 and CMTX, to be condu...

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

All randomised patients with Charcot-Marie-Tooth Type 1A (CMT1A) who completed the primary study CLN-PXT3003-02, i.e. 15-month double-blind treatment with PXT3003 or placebo, will be eligi...

Companies [26 Associated Companies listed on BioPortfolio]

Constance Marie

Ella Marie Foundation

The Ella Marie Foundation was founded in 1998 with a simple desire of helping others. Over the past 16 years, that mission has expanded into a cohesive effort to enhance the lives...

Constance Therapeutics

Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole plant cannabis extracts. The company has created a new ...

GATC Biotech AG .

GATC Biotech, with headquarters in Constance, Germany, at the beautiful Lake Constance, is a leading provider of molecular biological services & innovative bioinformatics solutions for industry & acad...

Marie Claire

More Information about "Constance Marie" on BioPortfolio

We have published hundreds of Constance Marie news stories on BioPortfolio along with dozens of Constance Marie Clinical Trials and PubMed Articles about Constance Marie for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Constance Marie Companies in our database. You can also find out about relevant Constance Marie Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record